Evidence map›Paper›PMID 40176808›Full record

ArticleFrontiers in immunology2025

Oropharyngeal carcinomas induce circulating monocytes to express a TAM-like pro-tumor expression profile that suppresses T-cell proliferation.

Christopher J Papayannakos, Mohd Israr, James A DeVoti, Fung Lam, Arnon Arazi, Douglas K Frank, Dev P Kamdar, Lucio M Pereira, Nagashree Seetharamu, Bettie M Steinberg and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christopher J Papayannakos *Northwell, New Hyde Park, NY, United States.
Mohd Israr *Northwell, New Hyde Park, NY, United States.
James A DeVotiNorthwell, New Hyde Park, NY, United States.
Fung LamNorthwell, New Hyde Park, NY, United States.
Arnon AraziNorthwell, New Hyde Park, NY, United States.
Douglas K FrankNorthwell, New Hyde Park, NY, United States.
Dev P KamdarNorthwell, New Hyde Park, NY, United States.
Lucio M PereiraNorthwell, New Hyde Park, NY, United States.
Nagashree SeetharamuNorthwell, New Hyde Park, NY, United States.
Bettie M SteinbergNorthwell, New Hyde Park, NY, United States.
Vincent R BonaguraNorthwell, New Hyde Park, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Tumor-associated macrophages (TAMs) recruited from circulating monocytes drive tumor-growth and establish an immunosuppressive tumor microenvironment (TME). Initial events in transition from resting monocytes to TAMs are poorly understood. Here, we report that monocytes from oropharyngeal cancer (OPC) patients and control monocytes treated with OPC-conditioned media (CM) express a repertoire of pro-tumor mediators that is characteristic of TAMs. Methods: Monocytes were stimulated with OPC cell line CM, analyzed by single-cell RNAseq. Results of select genes were confirmed by qPCR with monocytes and analyzed in OPC tumors vs. clinically normal tissue. OPC spheroids containing control monocytes and T-cells were established, TAM phenotype characterized by flow analysis and qPCR, and T-cell proliferation assessed by flow. Results: OPC-conditioned media induced multiple pro-tumor genes including Conclusion: Targeting the early transition of monocytes into pro-tumor TAMs could be used to develop new therapies for OPC.

Indexed as

MonocytesOropharyngeal NeoplasmsT-LymphocytesTumor-Associated MacrophagesCell Line, TumorCell ProliferationCulture Media, ConditionedFemaleGene Expression Regulation, NeoplasticHumansLymphocyte ActivationMaleTumor MicroenvironmentCulture Media, Conditionedmonocytesoropharyngeal cancersingle Cell RNA sequencingspheroidT-cell suppressiontumor associate macrophages (TAM)

Identifiers

PMID40176808
PMCPMC11961958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.